Translation initiation factor eIF4H, eIF4A and elongation factor eEF1A1 are essential in viral infections (10, 191, 200), which suggests that translation factors can be used as drug targets for the treatment of SARS-CoV-2 infections and have therapeutic potential (10). This evidence concerns the gene EEF1A1 and viral infectious disease.